Genetically determined amino acid substitutions in the platelet adhesive A1 domain alter von Willebrand factor’s (VWF) platelet agglutination competence, resulting in both gain- (type 2B) and loss-of-function...
Leer más

Desmopressin (1-desamino-8-d-arginine vasopressin [DDAVP]) can be used to prevent or stop bleeding. However, large interindividual variability is observed in DDAVP response and determinants are largely...
Leer más

The American Society of Hematology (ASH), International Society on Thrombosis and Hemostasis (ISTH), National Hemophilia Foundation (NHF, now National Bleeding Disorders Foundation NBDF) and World Federation...
Leer más

Von Willebrand disease (VWD) is a hereditary bleeding disorder characterized by a quantitative or qualitative deficiency of von Willebrand factor (VWF). Pregnancy significantly impacts hemostasis, leading to a hypercoagulable state. However, women with VWD experience unique challenges due to the interplay between pregnancy-related hormonal changes and VWF deficiencies. This review delves into the intricate relationship between VWD and pregnancy. We...
Leer más